Alembic Pharmaceuticals (APLLTD) Shareholding Pattern

NSE: APLLTD • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 69.74%
FII Holding 4.24%
DII Holding 16.17%
Public Holding 6.87%
Total Shareholders 87,000
As of Dec 2025
View the latest shareholding pattern of Alembic Pharmaceuticals (APLLTD) including promoter, FII, DII, and public holdings. Track APLLTD ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See APLLTD intrinsic value calculation)

Alembic Pharmaceuticals (APLLTD) Shareholding Summary

  • Promoter holding remains unchanged at 69.74% in Dec 2025
  • FII/FPI have increased holdings from 4.05% to 4.24% in Dec 2025
  • DIIs have decreased holdings from 16.30% to 16.17% in Dec 2025
  • Institutional investors have increased holdings from 20.35% to 20.41% in Dec 2025
  • Number of shareholders decreased from 89,969 to 87,000 in Dec 2025

APLLTD Quarterly Ownership Changes

Quarter-over-quarter changes for Alembic Pharmaceuticals from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
+0.19%
DII Holding Change
Sept 2025 to Dec 2025
-0.13%
Public Holding Change
Sept 2025 to Dec 2025
-0.06%

Alembic Pharmaceuticals (APLLTD) Quarterly Shareholding Trends

Visual breakdown of APLLTD ownership distribution over time. Learn more about APLLTD dividend growth.

Promoter
FII
DII
Public
Government

Rising institutional holdings in APLLTD often correlate with improved fundamentals. Check out APLLTD price book multiple.

Alembic Pharmaceuticals (APLLTD) Shareholding Data

Download complete APLLTD ownership data for offline analysis. Discover APLLTD earnings valuation.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 69.74% 4.24% 16.17% 0.00% 6.87% 2.98% 100.00% 87,000
Sept 2025 69.74% 4.05% 16.30% 0.00% 6.93% 2.99% 100.01% 89,969
Jun 2025 69.67% 3.96% 16.46% 0.00% 7.01% 2.89% 99.99% 89,013
Mar 2025 69.67% 3.94% 16.43% 0.00% 7.07% 2.88% 99.99% 91,336
Dec 2024 69.61% 4.17% 16.06% 0.00% 7.26% 2.90% 100.00% 93,944
Sept 2024 69.61% 3.94% 16.05% 0.00% 7.36% 3.04% 100.00% 91,429
Jun 2024 69.61% 4.32% 15.47% 0.00% 7.48% 3.13% 100.01% 74,829
Mar 2024 69.61% 4.46% 15.38% 0.00% 7.41% 3.14% 100.00% 76,567
Dec 2023 69.61% 4.52% 14.50% 0.00% 8.00% 3.37% 100.00% 85,212
Sept 2023 69.61% 0.00% 13.93% 0.00% 8.24% 8.22% 100.00% 89,552
Jun 2023 69.61% 0.00% 13.40% 0.00% 8.98% 8.01% 100.00% 97,607
Mar 2023 69.61% 0.00% 13.31% 0.00% 9.08% 8.00% 100.00% 103,811
Dec 2022 69.61% 0.00% 12.76% 0.00% 9.21% 8.42% 100.00% 101,457
Sept 2022 69.61% 0.00% 12.43% 0.00% 9.12% 8.84% 100.00% 106,437
Jun 2022 69.61% 0.00% 12.06% 0.00% 8.91% 9.41% 99.99% 110,038
Mar 2022 69.61% 0.00% 11.69% 0.00% 9.22% 9.47% 99.99% 123,059
Dec 2021 69.48% 0.00% 11.56% 0.00% 9.57% 9.39% 100.00% 101,686
Sept 2021 69.48% 0.00% 11.36% 0.00% 11.43% 7.73% 100.00% 99,809
Jun 2021 69.48% 0.00% 11.17% 0.00% 10.78% 8.57% 100.00% 0
Mar 2021 69.48% 0.00% 10.92% 0.00% 10.99% 8.61% 100.00% 0

APLLTD promoter holding above 50% indicates strong insider confidence. Explore the Alembic Pharmaceuticals networth for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 69.74% 4.24% 16.17% 0.00% 6.87% 2.98% 100.00% 87,000
Sept 2025 69.74% 4.05% 16.30% 0.00% 6.93% 2.99% 100.01% 89,969
Jun 2025 69.67% 3.96% 16.46% 0.00% 7.01% 2.89% 99.99% 89,013
Mar 2025 69.67% 3.94% 16.43% 0.00% 7.07% 2.88% 99.99% 91,336
Dec 2024 69.61% 4.17% 16.06% 0.00% 7.26% 2.90% 100.00% 93,944
Sept 2024 69.61% 3.94% 16.05% 0.00% 7.36% 3.04% 100.00% 91,429
Jun 2024 69.61% 4.32% 15.47% 0.00% 7.48% 3.13% 100.01% 74,829
Mar 2024 69.61% 4.46% 15.38% 0.00% 7.41% 3.14% 100.00% 76,567
Dec 2023 69.61% 4.52% 14.50% 0.00% 8.00% 3.37% 100.00% 85,212
Sept 2023 69.61% 0.00% 13.93% 0.00% 8.24% 8.22% 100.00% 89,552
Jun 2023 69.61% 0.00% 13.40% 0.00% 8.98% 8.01% 100.00% 97,607
Mar 2023 69.61% 0.00% 13.31% 0.00% 9.08% 8.00% 100.00% 103,811

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 69.74% 4.24% 16.17% 0.00% 6.87% 2.98% 100.00% 87,000
Dec 2024 69.61% 4.17% 16.06% 0.00% 7.26% 2.90% 100.00% 93,944
Dec 2023 69.61% 4.52% 14.50% 0.00% 8.00% 3.37% 100.00% 85,212
Dec 2022 69.61% 0.00% 12.76% 0.00% 9.21% 8.42% 100.00% 101,457
Dec 2021 69.48% 0.00% 11.56% 0.00% 9.57% 9.39% 100.00% 101,686

Year-over-year trends reveal long-term ownership shifts.

Understanding Alembic Pharmaceuticals (APLLTD) Shareholding Pattern

Alembic Pharmaceuticals shareholding pattern reveals who owns APLLTD stock and how ownership changes over time. High promoter stakes in APLLTD often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your APLLTD trades. APLLTD 52-week high low

Combine APLLTD ownership analysis with price movements and financial performance for a complete investment picture. (See APLLTD investment value)